WHO(World Health Organization) has approved the use of the vaccine Covaxin for emergency use in India. Bharat Biotech published data suggesting 78% efficacy of this vaccine that was produced. In a tweet WHO mentioned that the benefits far outweigh the risks. The vaccine was approved with the following conditions:
It is recommended for being used in two doses, with a dose interval of four weeks, for all age groups above 18.
Covaxin has a 78% efficacy against Covid 19. Extremely suitable for low- middle income states, due to its easy storage requirements.
The current data is insufficient as to knowing it’s efficacy with regard to pregnant women.